INTRODUCTION AND AIM OF THE MEETING
We want to dedicate our Autumn Focus Workshop (FW) to Biomarker Assay Validation best practices. Seven years into the EBF Biomarker Recommendation (Bioanalysis (2012) 4(15), 1883–1894), the EBF sees an ongoing need to connect the stakeholders to ensure a science-driven approach to biomarker analysis.
At the workshop, we wish to engage with all delegates to reach the optimized management of the day-to-day challenges related to the following 3 areas:
- Development, validation and use of biomarker assays in the regulatory space the exploratory space.
- Understanding the principles of Context of Use and bringing them into practice
- Developing and/or optimizing communication and scientific interactions between end-user of the biomarker data and the bioanalytical scientist (Pharma or CRO).
WHO SHOULD ATTEND?
Scientists and managers from Pharma R&D, CRO and Health Authorities involved in research, assay validation & analysis, data interpretation and/or filing of biomarkers data.